Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00904605 · ClinicalTrials.gov registry record · Phase 4
Lidocaine Patch Versus Celecoxib in Pain From Osteoarthritis of the Knee
A Phase 4 study, sponsored by Endo USA Inc., a Keenova Therapeutics Company.
- Terminated
- Registry status
- Phase 4
- Development phase
NCT00904605: Clinical Trial Phase 4 study, sponsored by Endo USA Inc., a Keenova Therapeutics Company.
NCT00904605 is a Phase 4 study that was terminated before completion, run by Endo USA Inc., a Keenova Therapeutics Company. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00904605, a Phase 4 study, was terminated before completion, sponsored by Endo USA Inc., a Keenova Therapeutics Company.
- TERMINATED
- Registry status
- Phase 4
- Development phase
Study Summary
Patients with unilateral or bilateral osteoarthritis of the knee participated in a Phase IV clinical trial to assess the efficacy of Lidoderm compared with celecoxib 200mg in treating pain from osteoarthritis of the knee.
Interventions
- DRUG Celecoxib
- DRUG Lidoderm
Trial Details
| Field | Value |
|---|---|
| Start Date | 2004-06 |
| Est. Completion | 2004-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00904605
The ClinicalTrials.gov registry entry for NCT00904605 describes a study currently listed as terminated, categorized as Phase 4. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Endo USA Inc., a Keenova Therapeutics Company, which has 61 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Celecoxib is the first listed.
NCT00904605 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00904605 about?
NCT00904605 is a clinical study titled "Lidocaine Patch Versus Celecoxib in Pain From Osteoarthritis of the Knee". Patients with unilateral or bilateral osteoarthritis of the knee participated in a Phase IV clinical trial to assess the efficacy of Lidoderm compared with celecoxib 200mg in treating pain from osteoarthritis of the knee.
What is the current status of trial NCT00904605?
This trial is currently terminated. It is a Phase 4 study. The study started on 2004-06. Estimated completion is 2004-11.
What interventions are being tested in trial NCT00904605?
The interventions under investigation include: Celecoxib (DRUG), Lidoderm (DRUG).
Who is sponsoring clinical trial NCT00904605?
This trial is sponsored by Endo USA Inc., a Keenova Therapeutics Company, which has 61 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.